On Tuesday, Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) was -4.98% drop from the session before settling in for the closing price of $25.12. A 52-week range for AMPH has been $22.64 – $53.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 18.07% over the last five years. When this article was written, the company’s average yearly earnings per share was at -19.14%. With a float of $35.08 million, this company’s outstanding shares have now reached $47.62 million.
The firm has a total of 2028 workers. Let’s measure their productivity. In terms of profitability, gross margin is 50.4%, operating margin of 28.14%, and the pretax margin is 25.99%.
Amphastar Pharmaceuticals Inc (AMPH) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Amphastar Pharmaceuticals Inc stocks. The insider ownership of Amphastar Pharmaceuticals Inc is 26.15%, while institutional ownership is 74.50%. The most recent insider transaction that took place on May 01 ’25, was worth 12,041. In this transaction Director of this company sold 500 shares at a rate of $24.08, taking the stock ownership to the 73,409 shares. Before that another transaction happened on May 01 ’25, when Company’s Director proposed sale 500 for $24.19, making the entire transaction worth $12,095.
Amphastar Pharmaceuticals Inc (AMPH) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -19.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.03% during the next five years compared to 25.59% growth over the previous five years of trading.
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Trading Performance Indicators
You can see what Amphastar Pharmaceuticals Inc (AMPH) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.55. Likewise, its price to free cash flow for the trailing twelve months is 6.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.06, a number that is poised to hit 0.69 in the next quarter and is forecasted to reach 3.70 in one year’s time.
Technical Analysis of Amphastar Pharmaceuticals Inc (AMPH)
Analysing the last 5-days average volume posted by the [Amphastar Pharmaceuticals Inc, AMPH], we can find that recorded value of 0.63 million was better than the volume posted last year of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 67.05%. Additionally, its Average True Range was 0.98.
During the past 100 days, Amphastar Pharmaceuticals Inc’s (AMPH) raw stochastic average was set at 5.41%, which indicates a significant decrease from 45.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.61% in the past 14 days, which was lower than the 39.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.49, while its 200-day Moving Average is $38.84. Now, the first resistance to watch is $24.71. This is followed by the second major resistance level at $25.55. The third major resistance level sits at $26.06. If the price goes on to break the first support level at $23.36, it is likely to go to the next support level at $22.85. Now, if the price goes above the second support level, the third support stands at $22.01.
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Key Stats
There are 47,502K outstanding shares of the company, which has a market capitalization of 1.13 billion. As of now, sales total 731,970 K while income totals 159,520 K. Its latest quarter income was 186,520 K while its last quarter net income were 37,960 K.
